25 XP   0   0   10

Repare Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Repare Therapeutics Inc together

PenkeI guess you are interested in Repare Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Repare Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Repare Therapeutics Inc

I send you an email if I find something interesting about Repare Therapeutics Inc.

Quick analysis of Repare Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Repare Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.03
Expected worth in 1 year
$3.43
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-1.60
Return On Investment
-50.8%

For what price can you sell your share?

Current Price per Share
$3.15
Expected price per share
$0 - $5.08
How sure are you?
50%

1. Valuation of Repare Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$3.15

Intrinsic Value Per Share

$-28.46 - $-33.52

Total Value Per Share

$-23.43 - $-28.50

2. Growth of Repare Therapeutics Inc (5 min.)




Is Repare Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$212m$267.3m-$31.8m-13.5%

How much money is Repare Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$23.4m-$7.2m-$16.1m-69.0%
Net Profit Margin-436.0%-3,559.0%--

How much money comes from the company's main activities?

3. Financial Health of Repare Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#244 / 1016

Most Revenue
#278 / 1016

Most Profit
#722 / 1016

Most Efficient
#730 / 1016

What can you expect buying and holding a share of Repare Therapeutics Inc? (5 min.)

Welcome investor! Repare Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Repare Therapeutics Inc.

What can you expect buying and holding a share of Repare Therapeutics Inc?

First you should know what it really means to hold a share of Repare Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Repare Therapeutics Inc is $3.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Repare Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Repare Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.03. Based on the TTM, the Book Value Change Per Share is $-0.40 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Repare Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.66-21.1%-0.56-17.6%-0.19-6.1%-0.44-13.9%-0.44-13.9%
Usd Book Value Change Per Share-0.50-16.0%-0.40-12.7%-0.05-1.7%0.309.4%0.309.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.50-16.0%-0.40-12.7%-0.05-1.7%0.309.4%0.309.4%
Usd Price Per Share7.30-9.95-13.77-17.66-17.66-
Price to Earnings Ratio-2.75--5.45--2.83--8.97--8.97-
Price-to-Total Gains Ratio-14.47--37.00--20.03--38.90--38.90-
Price to Book Ratio1.45-1.78-2.23-2.82-2.82-
Price-to-Total Gains Ratio-14.47--37.00--20.03--38.90--38.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.15
Number of shares317
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.400.30
Usd Total Gains Per Share-0.400.30
Gains per Quarter (317 shares)-126.6993.75
Gains per Year (317 shares)-506.78375.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-507-5170375365
20-1014-10240750740
30-1520-1531011251115
40-2027-2038015001490
50-2534-2545018751865
60-3041-3052022502240
70-3547-3559026252615
80-4054-4066030002990
90-4561-4573033753365
100-5068-5080037503740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.016.00.05.9%1.016.00.05.9%1.016.00.05.9%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%3.014.00.017.6%3.014.00.017.6%3.014.00.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%3.014.00.017.6%3.014.00.017.6%3.014.00.017.6%

Fundamentals of Repare Therapeutics Inc

About Repare Therapeutics Inc

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair. The company's lead product candidate is Camonsertib (RP-3500), an oral small molecule inhibitor under Phase ½ development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing Lunresertib (RP-6306), a PKMYT1 Inhibitor, which is under Phase 1 clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; RP-1664, an oral PLK4 inhibitor, under Phase 1 clinical trial designed to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, a polymerase theta adenosinetriphosphatase (ATPase) inhibitor, a SL target associated with BRCA mutations and other genomic alterations. The company has license and collaboration agreement with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; New York University; and Ono Pharmaceutical Co., as well as a clinical study and collaboration agreement with Debiopharm to explore the synthetic lethal combination of PKMYT1 and WEE1 inhibition in cancer. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada.

Fundamental data was last updated by Penke on 2024-04-12 17:30:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Repare Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Repare Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -214.8% means that $-2.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Repare Therapeutics Inc:

  • The MRQ is -214.8%. The company is making a huge loss. -2
  • The TTM is -436.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-214.8%TTM-436.0%+221.2%
TTM-436.0%YOY-3,559.0%+3,123.0%
TTM-436.0%5Y-3,596.5%+3,160.4%
5Y-3,596.5%10Y-3,596.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-214.8%-199.6%-15.2%
TTM-436.0%-213.0%-223.0%
YOY-3,559.0%-279.3%-3,279.7%
5Y-3,596.5%-438.4%-3,158.1%
10Y-3,596.5%-605.5%-2,991.0%
1.1.2. Return on Assets

Shows how efficient Repare Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • -11.0% Return on Assets means that Repare Therapeutics Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Repare Therapeutics Inc:

  • The MRQ is -11.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-8.0%-3.0%
TTM-8.0%YOY-3.2%-4.8%
TTM-8.0%5Y-6.5%-1.5%
5Y-6.5%10Y-6.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.0%-13.5%+2.5%
TTM-8.0%-12.9%+4.9%
YOY-3.2%-11.8%+8.6%
5Y-6.5%-14.1%+7.6%
10Y-6.5%-16.0%+9.5%
1.1.3. Return on Equity

Shows how efficient Repare Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • -13.2% Return on Equity means Repare Therapeutics Inc generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Repare Therapeutics Inc:

  • The MRQ is -13.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.2%TTM-10.0%-3.2%
TTM-10.0%YOY-4.2%-5.8%
TTM-10.0%5Y-6.7%-3.3%
5Y-6.7%10Y-6.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-16.9%+3.7%
TTM-10.0%-16.1%+6.1%
YOY-4.2%-15.1%+10.9%
5Y-6.7%-19.9%+13.2%
10Y-6.7%-20.9%+14.2%

1.2. Operating Efficiency of Repare Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Repare Therapeutics Inc is operating .

  • Measures how much profit Repare Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -233.4% means the company generated $-2.33  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Repare Therapeutics Inc:

  • The MRQ is -233.4%. The company is operating very inefficient. -2
  • The TTM is -671.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-233.4%TTM-671.3%+437.9%
TTM-671.3%YOY-3,570.9%+2,899.6%
TTM-671.3%5Y-3,782.3%+3,110.9%
5Y-3,782.3%10Y-3,782.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-233.4%-295.1%+61.7%
TTM-671.3%-225.8%-445.5%
YOY-3,570.9%-288.4%-3,282.5%
5Y-3,782.3%-477.4%-3,304.9%
10Y-3,782.3%-625.6%-3,156.7%
1.2.2. Operating Ratio

Measures how efficient Repare Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.33 means that the operating costs are $3.33 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Repare Therapeutics Inc:

  • The MRQ is 3.334. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.834. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.334TTM7.834-4.500
TTM7.834YOY37.120-29.286
TTM7.8345Y38.529-30.696
5Y38.52910Y38.5290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3343.090+0.244
TTM7.8343.264+4.570
YOY37.1203.783+33.337
5Y38.5295.679+32.850
10Y38.5297.894+30.635

1.3. Liquidity of Repare Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Repare Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.24 means the company has $6.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Repare Therapeutics Inc:

  • The MRQ is 6.236. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.339. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.236TTM5.339+0.897
TTM5.339YOY6.882-1.543
TTM5.3395Y14.781-9.442
5Y14.78110Y14.7810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2363.914+2.322
TTM5.3394.220+1.119
YOY6.8825.388+1.494
5Y14.7816.045+8.736
10Y14.7816.406+8.375
1.3.2. Quick Ratio

Measures if Repare Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.99 means the company can pay off $8.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Repare Therapeutics Inc:

  • The MRQ is 8.989. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.065. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.989TTM8.065+0.924
TTM8.065YOY8.335-0.270
TTM8.0655Y15.710-7.645
5Y15.71010Y15.7100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9893.572+5.417
TTM8.0653.998+4.067
YOY8.3355.390+2.945
5Y15.7105.969+9.741
10Y15.7106.287+9.423

1.4. Solvency of Repare Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Repare Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Repare Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.16 means that Repare Therapeutics Inc assets are financed with 16.5% credit (debt) and the remaining percentage (100% - 16.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Repare Therapeutics Inc:

  • The MRQ is 0.165. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.197. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.165TTM0.197-0.033
TTM0.197YOY0.246-0.049
TTM0.1975Y0.373-0.175
5Y0.37310Y0.3730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1650.336-0.171
TTM0.1970.334-0.137
YOY0.2460.269-0.023
5Y0.3730.366+0.007
10Y0.3730.390-0.017
1.4.2. Debt to Equity Ratio

Measures if Repare Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 19.7% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Repare Therapeutics Inc:

  • The MRQ is 0.197. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.248. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.197TTM0.248-0.051
TTM0.248YOY0.328-0.080
TTM0.2485Y0.247+0.001
5Y0.24710Y0.2470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1970.382-0.185
TTM0.2480.396-0.148
YOY0.3280.335-0.007
5Y0.2470.434-0.187
10Y0.2470.465-0.218

2. Market Valuation of Repare Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Repare Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Repare Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -2.75 means the investor is paying $-2.75 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Repare Therapeutics Inc:

  • The EOD is -1.185. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.746. Based on the earnings, the company is expensive. -2
  • The TTM is -5.451. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.185MRQ-2.746+1.561
MRQ-2.746TTM-5.451+2.704
TTM-5.451YOY-2.830-2.621
TTM-5.4515Y-8.974+3.523
5Y-8.97410Y-8.9740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.185-2.259+1.074
MRQ-2.746-2.569-0.177
TTM-5.451-2.664-2.787
YOY-2.830-4.120+1.290
5Y-8.974-6.258-2.716
10Y-8.974-6.171-2.803
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Repare Therapeutics Inc:

  • The EOD is -1.163. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.696. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.235. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.163MRQ-2.696+1.533
MRQ-2.696TTM-3.235+0.539
TTM-3.235YOY-3.479+0.244
TTM-3.2355Y-6.866+3.632
5Y-6.86610Y-6.8660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.163-2.924+1.761
MRQ-2.696-3.246+0.550
TTM-3.235-3.488+0.253
YOY-3.479-5.620+2.141
5Y-6.866-8.315+1.449
10Y-6.866-8.826+1.960
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Repare Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.45 means the investor is paying $1.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Repare Therapeutics Inc:

  • The EOD is 0.627. Based on the equity, the company is cheap. +2
  • The MRQ is 1.452. Based on the equity, the company is underpriced. +1
  • The TTM is 1.777. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.627MRQ1.452-0.825
MRQ1.452TTM1.777-0.325
TTM1.777YOY2.228-0.451
TTM1.7775Y2.818-1.042
5Y2.81810Y2.8180.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6271.851-1.224
MRQ1.4522.090-0.638
TTM1.7772.095-0.318
YOY2.2282.844-0.616
5Y2.8183.466-0.648
10Y2.8183.815-0.997
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Repare Therapeutics Inc.

3.1. Institutions holding Repare Therapeutics Inc

Institutions are holding 94.568% of the shares of Repare Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Bvf Inc19.65762.7011829198800
2023-12-31Orbimed Advisors, LLC7.87650.4844332248800
2023-12-31Blue Owl Capital Holdings LP7.40245.4488312249931224990
2023-12-31Deep Track Capital, LP7.09480.72962992731-75000-2.4448
2023-09-30CHI Advisors LLC7.03314.20392966674-32060-1.0691
2023-12-31ARK Investment Management LLC6.6890.121928215602006777.6568
2023-12-31Versant Venture Management LLC6.27434.9687264665700
2023-09-30Redmile Group, LLC5.70071.38212404695-23640-0.9735
2023-12-31Mpm Asset Management, LLC5.31658.0448224263600
2023-12-31MPM Oncology Impact Management LP3.88752.8007163984900
2023-12-31Artal Group S A1.65950.169970000000
2023-12-31Aquilo Capital Management, LLC1.50132.88116332716332710
2023-12-31Logos Global Management LP1.42240.4089600000300000100
2023-12-31Renaissance Technologies Corp0.84350.004355826202926132.7181
2023-12-31Ensign Peak Advisors Inc0.81630.00534432800
2023-12-31Morgan Stanley - Brokerage Accounts0.790.0002333259282937562.2531
2023-12-31Nikko Asset Management Americas Inc0.77290.022932601100
2023-12-31Sumitomo Mitsui Trust Holdings Inc0.77290.001832601100
2023-12-31Millennium Management LLC0.43170.0006182097159410702.6491
2023-12-31HighVista Strategies LLC0.39160.437616517300
Total 86.334444.81836417753+4771020+13.1%

3.2. Funds holding Repare Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Genomic Revolution6.35180.78522679347-118395-4.2318
2024-03-28ARK Genomic Revolution ETF6.33480.7856267216200
2024-02-29Vanguard Health Care ETF0.13260.001955949-7172-11.3623
2024-03-31A4Investments SICAV SIF ACCI IlanaA2EURH0.11852.6521500001500042.8571
2023-12-31Biotech Growth Ord0.11680.08584925700
2023-06-30DekaLux-BioTech CF0.09480.12414000025400173.9726
2024-02-29Vifag 2002 SICAV0.0830.38023500000
2023-12-31Harbor Disruptive Innovation Instl0.07620.32183215121157.0416
2024-03-29Avantis US Small Cap Equity ETF0.06650.01322807100
2024-02-29Fidelity Nasdaq Composite Index0.06290.00122654400
2024-03-28Loncar Cancer Immunotherapy ETF0.05950.410925078434420.9511
2024-03-28SPDR® S&P International Small Cap ETF0.0470.01471980500
2024-03-29Dimensional US Small Cap ETF0.04320.00111823900
2024-03-29Harbor Disruptive Innovation ETF0.04230.24517829-212-1.1751
2023-06-30TD US Small-Cap Equity - I0.0270.04371137900
2024-03-31Zacks Quantitative Strategy0.01860.2434783478340
2024-03-31BMO ARK Genomic Revolution Series F0.01680.77667095-2942-29.3115
2023-10-20Loncar China BioPharma ETF0.01170.5753492600
2024-03-29Avantis US Equity ETF0.010.0003423100
2023-12-31JNL/DFA US Small Cap A0.00920.0047389300
Total 13.72327.46685788790-74028-1.3%

3.3. Insider Transactions

Insiders are holding 1.325% of the shares of Repare Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01Lloyd Mitchell SegalSELL24914.63
2024-04-01Michael ZindaSELL4104.66
2024-04-01Steve ForteSELL7894.61
2024-03-27Lloyd Mitchell SegalSELL26504.63
2024-03-27Michael ZindaSELL4504.62
2024-03-27Steve ForteSELL8254.62
2024-03-25Lloyd Mitchell SegalSELL26504.79
2024-03-25Michael ZindaSELL4504.78
2024-03-25Steve ForteSELL8254.79
2023-11-15Bvf Partners L P/ilBUY9315565
2023-11-02Bvf Partners L P/ilBUY7837093.6
2023-06-06Michael ZindaSELL120012.04

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Repare Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.505-0.400-21%-0.053-90%0.296-271%0.296-271%
Book Value Per Share--5.0285.584-10%6.257-20%5.319-5%5.319-5%
Current Ratio--6.2365.339+17%6.882-9%14.781-58%14.781-58%
Debt To Asset Ratio--0.1650.197-17%0.246-33%0.373-56%0.373-56%
Debt To Equity Ratio--0.1970.248-20%0.328-40%0.247-20%0.247-20%
Dividend Per Share----0%-0%-0%-0%
Eps---0.664-0.556-16%-0.192-71%-0.438-34%-0.438-34%
Free Cash Flow Per Share---0.677-0.765+13%-0.025-96%-0.334-51%-0.334-51%
Free Cash Flow To Equity Per Share---0.674-0.760+13%-0.020-97%0.292-331%0.292-331%
Gross Profit Margin--1.0041.001+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---33.525--------
Intrinsic Value_10Y_min---28.460--------
Intrinsic Value_1Y_max---1.981--------
Intrinsic Value_1Y_min---1.945--------
Intrinsic Value_3Y_max---7.004--------
Intrinsic Value_3Y_min---6.665--------
Intrinsic Value_5Y_max---13.292--------
Intrinsic Value_5Y_min---12.247--------
Market Cap132873930.000-132%307930060.000419712890.000-27%586793809.720-48%746212390.405-59%746212390.405-59%
Net Profit Margin---2.148-4.360+103%-35.590+1557%-35.965+1574%-35.965+1574%
Operating Margin---2.334-6.713+188%-35.709+1430%-37.823+1521%-37.823+1521%
Operating Ratio--3.3347.834-57%37.120-91%38.529-91%38.529-91%
Pb Ratio0.627-132%1.4521.777-18%2.228-35%2.818-48%2.818-48%
Pe Ratio-1.185+57%-2.746-5.451+98%-2.830+3%-8.974+227%-8.974+227%
Price Per Share3.150-132%7.3009.950-27%13.768-47%17.656-59%17.656-59%
Price To Free Cash Flow Ratio-1.163+57%-2.696-3.235+20%-3.479+29%-6.866+155%-6.866+155%
Price To Total Gains Ratio-6.242+57%-14.466-37.000+156%-20.033+38%-38.900+169%-38.900+169%
Quick Ratio--8.9898.065+11%8.335+8%15.710-43%15.710-43%
Return On Assets---0.110-0.080-28%-0.032-71%-0.065-41%-0.065-41%
Return On Equity---0.132-0.100-24%-0.042-68%-0.067-50%-0.067-50%
Total Gains Per Share---0.505-0.400-21%-0.053-90%0.296-271%0.296-271%
Usd Book Value--212082000.000235527000.000-10%267367500.000-21%225177294.118-6%225177294.118-6%
Usd Book Value Change Per Share---0.505-0.400-21%-0.053-90%0.296-271%0.296-271%
Usd Book Value Per Share--5.0285.584-10%6.257-20%5.319-5%5.319-5%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.664-0.556-16%-0.192-71%-0.438-34%-0.438-34%
Usd Free Cash Flow---28554000.000-32274000.000+13%-70000.000-100%-13839529.412-52%-13839529.412-52%
Usd Free Cash Flow Per Share---0.677-0.765+13%-0.025-96%-0.334-51%-0.334-51%
Usd Free Cash Flow To Equity Per Share---0.674-0.760+13%-0.020-97%0.292-331%0.292-331%
Usd Market Cap132873930.000-132%307930060.000419712890.000-27%586793809.720-48%746212390.405-59%746212390.405-59%
Usd Price Per Share3.150-132%7.3009.950-27%13.768-47%17.656-59%17.656-59%
Usd Profit---28030000.000-23449000.000-16%-7261750.000-74%-17146882.353-39%-17146882.353-39%
Usd Revenue--13047000.00012783250.000+2%32957500.000-60%11217529.412+16%11217529.412+16%
Usd Total Gains Per Share---0.505-0.400-21%-0.053-90%0.296-271%0.296-271%
 EOD+3 -5MRQTTM+17 -17YOY+10 -245Y+10 -2410Y+10 -24

4.2. Fundamental Score

Let's check the fundamental score of Repare Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.185
Price to Book Ratio (EOD)Between0-10.627
Net Profit Margin (MRQ)Greater than0-2.148
Operating Margin (MRQ)Greater than0-2.334
Quick Ratio (MRQ)Greater than18.989
Current Ratio (MRQ)Greater than16.236
Debt to Asset Ratio (MRQ)Less than10.165
Debt to Equity Ratio (MRQ)Less than10.197
Return on Equity (MRQ)Greater than0.15-0.132
Return on Assets (MRQ)Greater than0.05-0.110
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Repare Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.817
Ma 20Greater thanMa 504.013
Ma 50Greater thanMa 1005.389
Ma 100Greater thanMa 2005.962
OpenGreater thanClose3.020
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -428193-235-189-424172-25228028



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets253,901
Total Liabilities41,819
Total Stockholder Equity212,082
 As reported
Total Liabilities 41,819
Total Stockholder Equity+ 212,082
Total Assets = 253,901

Assets

Total Assets253,901
Total Current Assets243,688
Long-term Assets10,213
Total Current Assets
Cash And Cash Equivalents 111,268
Short-term Investments 112,359
Net Receivables 15,312
Other Current Assets 4,749
Total Current Assets  (as reported)243,688
Total Current Assets  (calculated)243,688
+/-0
Long-term Assets
Property Plant Equipment 7,541
Long-term Assets Other 396
Long-term Assets  (as reported)10,213
Long-term Assets  (calculated)7,937
+/- 2,276

Liabilities & Shareholders' Equity

Total Current Liabilities39,079
Long-term Liabilities2,740
Total Stockholder Equity212,082
Total Current Liabilities
Short-term Debt 2,400
Accounts payable 2,400
Other Current Liabilities 24,057
Total Current Liabilities  (as reported)39,079
Total Current Liabilities  (calculated)28,857
+/- 10,222
Long-term Liabilities
Capital Lease Obligations 3,410
Long-term Liabilities  (as reported)2,740
Long-term Liabilities  (calculated)3,410
+/- 670
Total Stockholder Equity
Common Stock483,350
Retained Earnings -333,109
Accumulated Other Comprehensive Income 28
Other Stockholders Equity 61,813
Total Stockholder Equity (as reported)212,082
Total Stockholder Equity (calculated)212,082
+/-0
Other
Capital Stock483,350
Cash and Short Term Investments 223,627
Common Stock Shares Outstanding 42,139
Current Deferred Revenue10,222
Liabilities and Stockholders Equity 253,901
Net Debt -107,858
Net Invested Capital 212,082
Net Working Capital 204,609
Property Plant and Equipment Gross 14,845
Short Long Term Debt Total 3,410



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
102,695
93,569
381,731
370,242
357,086
339,068
320,651
295,645
368,715
337,149
308,044
409,158
364,075
336,306
301,588
286,407
253,901
253,901286,407301,588336,306364,075409,158308,044337,149368,715295,645320,651339,068357,086370,242381,73193,569102,695000
   > Total Current Assets 
0
0
0
98,572
87,885
377,264
361,265
346,552
328,210
309,188
280,376
351,414
319,228
289,738
390,597
353,979
325,526
291,925
275,093
243,688
243,688275,093291,925325,526353,979390,597289,738319,228351,414280,376309,188328,210346,552361,265377,26487,88598,572000
       Cash And Cash Equivalents 
0
0
0
94,797
83,711
369,933
347,872
326,184
311,399
293,635
260,995
334,427
305,136
275,834
155,191
159,521
121,461
115,544
107,369
111,268
111,268107,369115,544121,461159,521155,191275,834305,136334,427260,995293,635311,399326,184347,872369,93383,71194,797000
       Short-term Investments 
0
0
0
0
0
0
0
7,526
7,497
7,160
7,194
7,439
6,528
6,255
215,162
184,420
192,663
165,148
142,703
112,359
112,359142,703165,148192,663184,420215,1626,2556,5287,4397,1947,1607,4977,5260000000
       Net Receivables 
0
0
0
3,056
3,399
4,035
4,869
6,164
5,432
6,264
3,084
3,234
3,649
4,407
14,609
4,323
7,013
7,032
19,470
15,312
15,31219,4707,0327,0134,32314,6094,4073,6493,2343,0846,2645,4326,1644,8694,0353,3993,056000
       Other Current Assets 
0
0
0
719
775
3,296
8,524
6,678
3,882
2,129
9,103
6,314
3,915
3,242
5,635
8,520
4,389
5,952
21,290
4,749
4,74921,2905,9524,3898,5205,6353,2423,9156,3149,1032,1293,8826,6788,5243,296775719000
   > Long-term Assets 
0
0
0
4,123
5,684
4,467
8,977
10,534
10,858
11,463
15,269
17,301
17,921
18,306
18,561
10,096
10,780
9,663
11,314
10,213
10,21311,3149,66310,78010,09618,56118,30617,92117,30115,26911,46310,85810,5348,9774,4675,6844,123000
       Property Plant Equipment 
0
0
0
3,424
3,110
3,182
8,268
8,622
8,769
8,866
11,418
13,095
12,400
11,580
10,587
9,599
10,372
9,255
8,605
7,541
7,5418,6059,25510,3729,59910,58711,58012,40013,09511,4188,8668,7698,6228,2683,1823,1103,424000
       Other Assets 
0
0
0
0
2,574
1,285
709
1,912
2,089
2,597
3,851
4,206
5,521
6,726
7,974
497
0
408
2,709
0
02,70940804977,9746,7265,5214,2063,8512,5972,0891,9127091,2852,5740000
> Total Liabilities 
0
0
0
148,824
151,704
68,075
69,444
70,256
71,415
75,562
77,392
80,294
78,489
82,527
103,382
84,558
85,062
56,174
53,039
41,819
41,81953,03956,17485,06284,558103,38282,52778,48980,29477,39275,56271,41570,25669,44468,075151,704148,824000
   > Total Current Liabilities 
0
0
0
4,246
7,307
9,797
10,193
11,014
12,420
23,223
23,410
35,089
34,083
39,440
61,871
78,619
80,935
53,253
48,972
39,079
39,07948,97253,25380,93578,61961,87139,44034,08335,08923,41023,22312,42011,01410,1939,7977,3074,246000
       Short-term Debt 
0
0
0
625
626
608
794
697
568
758
1,458
1,721
1,857
2,135
2,127
2,171
2,257
2,320
2,333
2,400
2,4002,3332,3202,2572,1712,1272,1351,8571,7211,458758568697794608626625000
       Accounts payable 
0
0
0
2,127
3,294
3,576
1,843
2,251
3,352
3,303
1,860
2,302
1,546
4,991
9,345
461
3,620
4,893
5,438
2,400
2,4005,4384,8933,6204619,3454,9911,5462,3021,8603,3033,3522,2511,8433,5763,2942,127000
       Other Current Liabilities 
0
0
0
4
3,116
-52,529
5,406
5,993
6,419
10,399
11,167
19,145
18,806
20,459
15,615
22,885
22,298
21,628
20,729
24,057
24,05720,72921,62822,29822,88515,61520,45918,80619,14511,16710,3996,4195,9935,406-52,5293,1164000
   > Long-term Liabilities 
0
0
0
144,578
144,397
58,278
59,251
59,242
58,995
52,339
53,982
45,205
44,406
43,087
41,511
5,939
4,127
2,921
4,067
2,740
2,7404,0672,9214,1275,93941,51143,08744,40645,20553,98252,33958,99559,24259,25158,278144,397144,578000
       Other Liabilities 
0
0
0
0
8,142
58,142
55,992
55,934
55,760
48,799
48,359
39,613
39,252
38,592
37,744
2,682
0
695
2,476
0
02,47669502,68237,74438,59239,25239,61348,35948,79955,76055,93455,99258,1428,1420000
> Total Stockholder Equity
0
0
0
-46,129
-58,135
313,656
300,798
286,830
267,653
245,089
218,253
288,421
258,660
225,517
305,776
279,517
251,244
245,414
233,368
212,082
212,082233,368245,414251,244279,517305,776225,517258,660288,421218,253245,089267,653286,830300,798313,656-58,135-46,129000
   Common Stock
0
0
0
1
521
383,818
383,852
384,313
384,610
385,454
385,990
480,699
481,048
481,380
481,782
482,032
482,677
482,739
483,184
483,350
483,350483,184482,739482,677482,032481,782481,380481,048480,699385,990385,454384,610384,313383,852383,8185211000
   Retained Earnings Total Equity000-274,2540-207,655-283,116-245,023-210,266-181,976-151,084-124,775-103,3580000000
   Accumulated Other Comprehensive Income 
0
0
0
-1,096
0
0
0
0
0
0
0
0
0
0
-524
-428
-235
-424
-252
28
28-252-424-235-428-5240000000000-1,096000
   Capital Surplus 
0
0
0
0
3,886
0
0
5,875
7,818
10,719
14,239
17,988
22,635
27,253
32,173
0
43,056
0
0
0
00043,056032,17327,25322,63517,98814,23910,7197,8185,875003,8860000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
4,907
3,886
4,182
5,041
5,875
7,818
10,719
14,239
17,988
22,635
27,253
32,173
37,226
43,056
49,299
55,515
61,813
61,81355,51549,29943,05637,22632,17327,25322,63517,98814,23910,7197,8185,8755,0414,1823,8864,907000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue51,133
Cost of Revenue-1,951
Gross Profit49,18249,182
 
Operating Income (+$)
Gross Profit49,182
Operating Expense-163,942
Operating Income-114,760-114,760
 
Operating Expense (+$)
Research Development130,294
Selling General Administrative33,764
Selling And Marketing Expenses116
Operating Expense163,942164,174
 
Net Interest Income (+$)
Interest Income13,159
Interest Expense-0
Other Finance Cost-0
Net Interest Income13,159
 
Pretax Income (+$)
Operating Income-114,760
Net Interest Income13,159
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-101,715-127,805
EBIT - interestExpense = -114,760
-101,715
-93,796
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-114,760-101,715
Earnings Before Interest and Taxes (EBITDA)-112,809
 
After tax Income (+$)
Income Before Tax-101,715
Tax Provision-5,455
Net Income From Continuing Ops-97,424-107,170
Net Income-93,796
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses165,893
Total Other Income/Expenses Net13,045-13,159
 

Technical Analysis of Repare Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Repare Therapeutics Inc. The general trend of Repare Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Repare Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Repare Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.08 < 3.43 < 5.08.

The bearish price targets are: .

Tweet this
Repare Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Repare Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Repare Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Repare Therapeutics Inc. The current macd is -0.62071592.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Repare Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Repare Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Repare Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Repare Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartRepare Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Repare Therapeutics Inc. The current adx is 45.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Repare Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Repare Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Repare Therapeutics Inc. The current sar is 3.5580288.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Repare Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Repare Therapeutics Inc. The current rsi is 21.82. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Repare Therapeutics Inc Daily Relative Strength Index (RSI) ChartRepare Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Repare Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Repare Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Repare Therapeutics Inc Daily Stochastic Oscillator ChartRepare Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Repare Therapeutics Inc. The current cci is -129.21923899.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Repare Therapeutics Inc Daily Commodity Channel Index (CCI) ChartRepare Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Repare Therapeutics Inc. The current cmo is -61.73728157.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Repare Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartRepare Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Repare Therapeutics Inc. The current willr is -89.82035928.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Repare Therapeutics Inc Daily Williams %R ChartRepare Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Repare Therapeutics Inc.

Repare Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Repare Therapeutics Inc. The current atr is 0.34406992.

Repare Therapeutics Inc Daily Average True Range (ATR) ChartRepare Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Repare Therapeutics Inc. The current obv is 38,479,051.

Repare Therapeutics Inc Daily On-Balance Volume (OBV) ChartRepare Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Repare Therapeutics Inc. The current mfi is 22.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Repare Therapeutics Inc Daily Money Flow Index (MFI) ChartRepare Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Repare Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Repare Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Repare Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.817
Ma 20Greater thanMa 504.013
Ma 50Greater thanMa 1005.389
Ma 100Greater thanMa 2005.962
OpenGreater thanClose3.020
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Repare Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Repare Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Repare Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Repare Therapeutics Inc

I send you an email if I find something interesting about Repare Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Repare Therapeutics Inc.

Receive notifications about Repare Therapeutics Inc in your mailbox!